IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in IDEAYA Biosciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 204
- 0 vs. Q1 2025
- Shares held
- 96.8M
- +2.97M (+3.2%) vs. Q1 2025
- Total value
- $2.04B
- +$493.5M (+32.0%) vs. Q1 2025
- New holders
- 31
- 78 more added
- Sold out
- 31
- 74 more reduced
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 6,206,238 | $130.4M | 0.06% | −195,543−3.1% | Reduced |
| Capital Research Global Investors | 6,552,691 | $137.7M | 0.03% | +3,817,768+139.6% | Added |
| BlackRock, Inc. | 8,842,635 | $185.9M | 0.00% | −313,882−3.4% | Reduced |
| FMR LLC | 13,137,294 | $276.1M | 0.02% | +6,800+0.1% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,347,252−100.0% | Sold out |
| Samlyn Capital, LLC | 0 | $0 | 0.00% | −791,266−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −526,688−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −445,000−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −430,161−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −357,600−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −190,421−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −65,500−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −49,824−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −42,333−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −39,500−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −30,215−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −19,673−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −16,641−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −13,788−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −11,727−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −6,659−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −3,898−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −2,250−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,860−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,703−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −528−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Sierra Ocean, LLC | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Aventura Private Wealth, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Orion Portfolio Solutions, LLC | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |
| Sandy Spring Bank | – | – | – | – | Not filed |